These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 8905223)

  • 1. Depressor effect of L-arginine in normotensive patients on regular dialysis treatment.
    Nakayama M; Nakano H; Yamada K; Miura Y; Tsuchida H; Kawaguchi Y; Sakai O
    Clin Nephrol; 1996 Oct; 46(4):286. PubMed ID: 8905223
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation of L-arginine transport in undialysed chronic renal failure and continuous ambulatory peritoneal dialysis patients.
    Brunini TM; Roberts NB; Yaqoob MM; Ellory JC; Mann GE; Mendes Ribeiro AC
    Clin Exp Pharmacol Physiol; 2006; 33(1-2):114-8. PubMed ID: 16445709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced nocturnal blood pressure fall is similar in continuous ambulatory peritoneal dialysis to that in hemodialysis and undialysed end-stage renal disease.
    Jones MA; Sharpstone P; Dallyn PE; Kingswood JC
    Clin Nephrol; 1994 Oct; 42(4):273-5. PubMed ID: 7834923
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased excretion of nitric oxide in exhaled air of patients with chronic renal failure.
    Matsumoto A; Hirata Y; Kakoki M; Nagata D; Momomura Si; Sugimoto T; Tagawa H; Omata M
    Clin Sci (Lond); 1999 Jan; 96(1):67-74. PubMed ID: 9857108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
    Stojimirović B; Grujić-Adanja G
    Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Peritoneal dialysis in the treatment of chronic renal failure].
    Kazimirov VG; Butrin SV; Bekov RR; Sapozhnikov AD; Kharitonov BI; Smoliakov AM; Detinenko IN
    Urologiia; 2004; (5):58-62. PubMed ID: 15560166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-arginine-nitric oxide pathway in end-stage renal disease.
    Prabhakar SS
    Am J Kidney Dis; 2002 Jan; 39(1):195-8; discussion 198-202. PubMed ID: 11774121
    [No Abstract]   [Full Text] [Related]  

  • 8. Outcome of peritoneal dialysis and hemodialysis in elderly patients with diabetes: early experience from Bangladesh.
    Iqbal MM; Islam MN; Mansur MA; Naeem GM; Sattar H; Hossain RM; Mohsin M; Rahman MH; Rashid HU
    Adv Perit Dial; 2005; 21():85-9. PubMed ID: 16686292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Levels of dimethyl-L-arginine in ultrafiltrate and blood pressure in patients during hemodialysis].
    Popławski A; Cieślak M; Kaliszewski Z; Pawlak K; Myśliwiec P
    Przegl Lek; 1995; 52(9):431-5. PubMed ID: 8834643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased L-arginine during peritonitis in ESRD patients on peritoneal dialysis.
    Suh H; Wadhwa NK; Peresleni T; McNurlan M; Garlick P; Goligorsky MS
    Adv Perit Dial; 1997; 13():205-9. PubMed ID: 9360682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ambulatory blood pressure monitoring of chronically dialyzed pediatric patients.
    Koch VH; Furusawa EA; Ignes E; Okay Y; Mion Junior D
    Blood Press Monit; 1999 Oct; 4(5):213-6. PubMed ID: 10547640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dialysis therapy of chronic renal failure in elderly patients].
    Tanaka Y; Shirai D
    Nihon Rinsho; 1992 Jan; 50 Suppl():96-101. PubMed ID: 1578794
    [No Abstract]   [Full Text] [Related]  

  • 13. [Systolic time interval changes in patients with chronic renal failure receiving regular dialysis treatment (author's transl)].
    Chvatíková J; Tomásek R; Král M; Turek T; Lachmanová J; Straková M; Ort J
    Cas Lek Cesk; 1978 Sep; 117(35):1092-5. PubMed ID: 709574
    [No Abstract]   [Full Text] [Related]  

  • 14. Seizures in dialysis patients treated with recombinant erythropoietin.
    Beccari M; Romagnoni M; Sorgato G
    Nephrol Dial Transplant; 1995; 10(3):423-4. PubMed ID: 7792048
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic effect of bromocriptine together with the established treatment for hypertension in patients undergoing peritoneal dialysis.
    Mejía-Rodríguez O; Alvarez-Aguilar C; Ledesma-Ramírez M; Paniagua-Sierra R
    Proc West Pharmacol Soc; 2004; 47():122-4. PubMed ID: 15633631
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful kidney transplantation does not reverse the coagulopathy in patients with chronic renal failure on either hemo or peritoneal dialysis.
    Ballow A; Gader AM; Huraib S; Mitwalli A; Al-Suleimani F; Al-Wakeel J
    Saudi J Kidney Dis Transpl; 2007 Jun; 18(2):177-85. PubMed ID: 17496391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of asymmetric dimethylarginine, nitric oxide and lipid peroxidation markers in patients with end-stage renal disease having peritoneal dialysis treatment.
    Göçmen AY; Sahin E; Koçak H; Tuncer M; Gümüşlü S
    Clin Biochem; 2008 Jul; 41(10-11):836-40. PubMed ID: 18457672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress and nitric oxide deficiency in inflammation of chronic renal failure. Possible preventive role of L-arginine and multiple antioxidants.
    Korish AA
    Saudi Med J; 2009 Sep; 30(9):1150-7. PubMed ID: 19750259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of infection in renal allograft recipients and patients in regular dialysis treatment.
    Boni RC; Soares VA; Caramori JC; Balbi AL; Corrêa LA; Carvalho MF
    Transplant Proc; 1996 Dec; 28(6):3376. PubMed ID: 8962315
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical analysis of 228 patients treated with penctoneal dialysis].
    Li J; Yang B; Cai Y
    Hunan Yi Ke Da Xue Xue Bao; 2002 Feb; 27(1):74-6. PubMed ID: 12575245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.